NEW YORK (GenomeWeb News) – Genomics services company Embark Scientific has purchased mouse genotyping assets from MendelWorks, an Identigene spin-off, for an undisclosed sum, Embark said earlier this week.
Austin, Tex.-based Embark said the deal will help increase its mouse genotyping capacity and its animal genotyping market share. The added capacity includes PCR and real-time PCR-based genotyping, gene expression, and RNA expression analysis, the company said.
In addition to mouse genotyping, Embark offers DNA sequencing, RNA expression analysis, assay development, and lab consulting services to clients in government, academia, and in industry.
Financial terms of the agreement were not released.